Global health is at a turning point. Funding cuts and isolationism are reshaping partnerships worldwide. Join us May 28 for the #RosenkranzGlobal Health Policy Symposium: 𝗗𝗿. 𝗖𝗵𝗲𝗹𝘀𝗲𝗮 𝗖𝗹𝗶𝗻𝘁𝗼𝗻 in conversation with 𝗦𝗲𝗰. 𝗖𝗼𝗻𝗱𝗼𝗹𝗲𝗲𝘇𝘇𝗮 𝗥𝗶𝗰𝗲, followed by panelist of global health experts. bit.ly/4wgybXs

Stanford researchers of all disciplines who are working on global health projects: Get your Rosenkranz Prize applications in by Friday! 🗓️‼️ bit.ly/3OLrAD8

New Year. New Ideas. Big Impact. See what our faculty, researchers and students at Stanford Health Policy have been up to. mailchi.mp/d893b7393e42...

What are the challenges in achieving #Medicare reimbursement for Breakthough Devices? Join our colleagues at Stanford Biodesign on Thursday for this webinar. Learn more & Register: bit.ly/4poYGFK

Last chance ⏳ ⏰ ‼️ to register for Wednesday’s Health Policy Forum, where Stanford experts David Relman and Hank Greely will examine the global health risks of engineered pathogens—and how to safeguard the public without stalling synthetic biology’s therapeutic promise. Register: bit.ly/3J9ILvV

Engineered pathogens designed by bad actors could threaten global health one day. Join our Nov. 19 Health Policy Forum with Stanford experts for a fascinating discussion of a rapidly emerging set of high-stakes scientific, ethical & regulatory challenges. Register: bit.ly/4984ted @law.stanford.edu

SHP's Michelle Mello testifies @ House Energy & Commerce health subcommittee about her optimism in safely advancing U.S. healthcare through the use of AI technologies. "AI presents both a historic opportunity and a serious risk," says prof of health policy & of law. www.youtube.com/live/avECrBU...

SHP researchers Marissa Reitsma & Sherri Rose, with Harvard's Thomas McGuire, develop 2 algorithms that can promote fairer #Medicare Advantage spending for minority populations. Learn more in this policy brief: bit.ly/4mE0Lgi

Considering a master's degree in health policy? We've got a vibrant, innovative program here at Stanford Health Policy. Learn more and ask questions at our upcoming live info session: bit.ly/3JGqTbL

Ready to shape the future of health policy? Learn more at our live info session about our PhD program. bit.ly/3JAe6Yk

What bold step will you take next to make your mark on the world? Perhaps an MS in health policy? Join us Sept. 10, at 10 am PT for live info session about the program. Learn about application & ask questions. Learn more & register: healthpolicy.fsi.stanford.edu/content/ms-h...

Considering a PhD in Health Policy? Discover our innovative program training the next generation of leaders in decision sciences, health economics and evaluative methods. Join info session Sept. 9 at 10 am to explore the application process and get your questions answered. bit.ly/479erLy

Eight academic health policy researchers present their global health projects—from Ethiopia to China to Argentina and beyond—during our annual #RosenkranzGlobal health symposium. See the slideshow. healthpolicy.fsi.stanford.edu/content/2025...

SHP"s Jason Wang and Ruth Gibson are working w/Taiwanese leaders in defense studies for civilian well-being, especially for children and women. In this Taipei Times editorial, they discuss health system capacity, supply chain reliability and community stability for naval blockades. bit.ly/3FuG3Pw

Qinyou Hu @utaustin.bsky.social presents research at Rosenkranz global health symposium on teen depression in China, noting ⬆️ ⬆️ among adolescents. Believes interventions to get parents to believe their children's abilities & interest = potential cure toward ⬇️ depression. Learn More: bit.ly/3ZmAVDN

Jon Denton-Schneider of Clark University notes 1/3 of new HIV infections in Zimbabwe hit 15-to-24-year-old women; they comprise only 1/10 of population. His research finds nationwide deworming program for schistosomiasis in children can lower chance of young women contracting HIV. bit.ly/4mpYUMk

Luiz Felipe Campos Fontes Insper research institute in Brazil gives evidence at Rosenkranz symposium about outsourcing management of hospital operations to private nonprofits under gov’t control. Finds hospital production up by 35%, access 20% and 3% in reduced mortality. Learn More: bit.ly/4drtTni

Virus expert Peter Piot (center) with our 2025 Rosenkranz Prize winners Jorge Luis Salinas and Fernando Alarid-Escudero, both of whom are devoted to improving public health in Mexico by fighting antimicrobial resistance and establishing a national colorectal cancer screening program. bit.ly/3OtRGHm

Robel Alemu, a postdoc research scientist at UCLA and the @broadinstitute.org, shows abrupt and prolonged loss of iodized salt in Ethiopian children harms later-life academic achievement, earnings & survival. @robel-alemu.bsky.social Learn More: bit.ly/3H0V5go

Yunwei Chen, postdoc scholar @fsi.stanford.edu SCCEI, shares research using a machine-learning approach to investigate improper antibiotic consumption in rural China, notes improving access to quality primary care = reduction of improper antibiotic use. Learn More: ywchen.io

Nicolás Roig of University of Alicante tells Rosenkranz global health symposium Latin America has highest 🌎 teen pregnancy rate after Sub-Saharan Africa. His study shows Argentina’s national pregnancy prevention plan resulted in 10% drop in pregnancies over one year. Learn More: nicolasroig.com

Nathan Franz, a PhD student in economics at @utaustin.bsky.social shares study on the newborn mortality advantage at public vs. private hospitals in northern India. Learn More: nathan-franz.github.io

Meiping Aggie Sun of Fordham University presents work at #RosenkranzGlobal on the long-term and multi-generational impacts of skilled birth attendance (SBA) = a 2.6% higher monthly income in adulthood if at least one parent experienced SBA. Learn More bit.ly/4k8QOGs

Peter Piot (center) congratulates Rosekranz Prize winners @stanfordmedicine.bsky.social's Jorge Luis Salinas and Fernando Alarid-Escudero, both of whom are working on projects to improve public health in Mexico: water monitoring to fight antimicrobial resistance & colorectal cancer screening.

Virus expert Peter Piot tells SHP Rosenkranz symposium cuts to global health aid = deaths. But believes scientific curiosity & research such as that presented at our conference will win out. “Nobody is rich enough not to learn from someone, and nobody’s poor enough not to have something to offer.”